Brief: BBS-Bioactive Bone Substitutes Estimates Will Receive CE Marking For Artebone Product

BBS-Bioactive Bone Substitutes Oyj

11/01/2021 14:15

Jan 11 (Reuters) - BBS-Bioactive Bone Substitutes Oyj
 BONEH.HE :
    * ESTIMATES IT WILL RECEIVE CE MARKING FOR ARTEBONE PRODUCT
DESIGNED TO HEAL BONE FRACTURES AND DAMAGES DURING 2021
    * OBTAINING OF CE MARKING WILL BE DELAYED FROM PREVIOUS
SCHEDULE
ABOUT 9 MONTHS
    * DELAY WILL CAUSE ADDITIONAL EXPENSES OF APPROXIMATELY EUR
300,000
    * INTENDS TO SUBMIT APPLICATION FOR PROCESSING IN
APPROXIMATELY
APRIL
    * APPROVAL OF CE MARKING IS EXPECTED TO BE COMPLETED BY END
OF
2021

Source text for Eikon:  ID:nGNE96MNrT 
Further company coverage:  BONEH.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))